{"Definition": "A  monocarboxylic acid amide that is the propyl amide of adenosine 5'-carboxylic acid.", "InChIKey": "UQGKLARJCHZHSS-QRIDJOKKSA-N", "Star": 3, "IUPAC Names": "1-(6-Amino-9H-purin-9-yl)-1-deoxy-N-propylribofuranuronamide", "SMILES": "CCCNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(N)ncnc12", "Mass": 322.3198, "Molfile": "\n\n  Marvin  10011014202D          \n\n 23 25  0  0  1  0            999 V2000\n   14.1648   -2.4354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   14.8769   -2.8521    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.5938   -2.4438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.3058   -2.8606    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   17.0228   -2.4523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   17.0277   -1.6274    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   19.9157   -2.4778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   19.1418   -2.7316    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   20.5418   -2.9219    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.2904   -2.3763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   21.0620   -1.6487    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   18.8795   -3.4802    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   20.1992   -1.6403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.4609   -2.2241    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   18.0548   -3.4802    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   17.8010   -2.6935    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0\n   22.0391   -2.7062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   20.6307   -3.7720    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   22.1406   -3.5944    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   21.4174   -4.1273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   19.1334   -4.2754    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   22.7073   -2.2197    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   17.7884   -4.2669    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  2  0  0  0  0\n  8  7  1  1  0  0  0\n  9  7  1  0  0  0  0\n 10  9  2  0  0  0  0\n 11 13  2  0  0  0  0\n 12  8  1  0  0  0  0\n 13  7  1  0  0  0  0\n 14  8  1  0  0  0  0\n 15 12  1  0  0  0  0\n 16 14  1  0  0  0  0\n 17 10  1  0  0  0  0\n 18  9  1  0  0  0  0\n 19 20  1  0  0  0  0\n 20 18  2  0  0  0  0\n 12 21  1  6  0  0  0\n 22 17  1  0  0  0  0\n 15 23  1  6  0  0  0\n 16  5  1  1  0  0  0\n 11 10  1  0  0  0  0\n 16 15  1  0  0  0  0\n 19 17  2  0  0  0  0\nM  END", "Secondary ChEBI ID": ["CHEBI:705348", "CHEBI:206536", "CHEBI:277343"], "Synonyms": ["(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxy-N-propyltetrahydrofuran-2-carboxamide"], "Monoisotopic Mass": ["322.139"], "PubChem Database Links": ["CID: 3044933", "SID: 85339942"], "PubMed Citation Links": ["10212124", "11170630", "7365748"], "Charge": 0, "ChEBI ID": "CHEBI:140261", "Formulae": "C13H18N6O4", "InChI": "InChI=1S/C13H18N6O4/c1-2-3-15-12(22)9-7(20)8(21)13(23-9)19-5-18-6-10(14)16-4-17-11(6)19/h4-5,7-9,13,20-21H,2-3H2,1H3,(H,15,22)(H2,14,16,17)/t7-,8+,9-,13+/m0/s1", "ChEBI Name": "adenosine-5'-(N-propyl)carboxamide", "CAS Registry Numbers": ["57872-80-7"]}
{"Definition": "The sodium salt of bromfenac. Note that 'bromfenac sodium' commonly refers to the sesquihydrate (120638-55-3); this is the anhydrous form.", "InChIKey": "HZFGMQJYAFHESD-UHFFFAOYSA-M", "Star": 3, "IUPAC Names": "sodium [2-amino-3-(4-bromobenzoyl)phenyl]acetate", "SMILES": "[Na+].Nc1c(CC([O-])=O)cccc1C(=O)c1ccc(Br)cc1", "Mass": 356.147, "Molfile": "\n\n  Marvin  04091011102D          \n\n 21 21  0  0  0  0            999 V2000\n    9.2103    0.9742    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n    6.4529   -1.4975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1698   -1.0839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7416   -1.0839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.3133   -1.0839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5963    0.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5963   -1.5028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8794   -0.2623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.8867    0.1511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.3133   -0.2623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    7.1698   -0.2623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8794   -1.0893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7416   -0.2623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    8.6036   -0.2623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.4529    0.1511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.0301    0.1458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.1628   -1.5028    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0\n    6.4529    0.9783    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    8.6036   -1.0839    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    9.3204    0.1511    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n    5.0301    0.9730    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  2  3  2  0  0  0  0\n  2  4  1  0  0  0  0\n  3 11  1  0  0  0  0\n  4 13  2  0  0  0  0\n  5  7  1  0  0  0  0\n  5 10  2  0  0  0  0\n  6  8  2  0  0  0  0\n  6 10  1  0  0  0  0\n  7 12  2  0  0  0  0\n  8 12  1  0  0  0  0\n  9 11  1  0  0  0  0\n  9 14  1  0  0  0  0\n 10 16  1  0  0  0  0\n 11 15  2  0  0  0  0\n 12 17  1  0  0  0  0\n 13 15  1  0  0  0  0\n 13 16  1  0  0  0  0\n 14 19  2  0  0  0  0\n 14 20  1  0  0  0  0\n 15 18  1  0  0  0  0\n 16 21  2  0  0  0  0\nM  CHG  2   1   1  20  -1\nM  END", "Synonyms": ["Sodium; [2-amino-3-(4-bromo-benzoyl)-phenyl]-acetate", "bromfenac sodium"], "Monoisotopic Mass": ["354.982"], "PubChem Database Links": ["CID: 23693301", "SID: 85340215"], "Beilstein Registry Numbers": ["6034130"], "Charge": 0, "ChEBI ID": "CHEBI:140536", "Formulae": "C15H11BrNNaO3", "InChI": "InChI=1S/C15H12BrNO3.Na/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19;/h1-7H,8,17H2,(H,18,19);/q;+1/p-1", "ChEBI Name": "bromfenac sodium salt", "CAS Registry Numbers": ["91714-93-1"]}
{"Definition": "A trimethyl-substituted thiazolidine carboxylic acid derived by cleavage of and loss of C<bond>2</bond>O from the azetidine ring of penicillanic acid.", "InChIKey": "MQQSPQRNCBFBSG-AKGZTFGVSA-N", "Star": 3, "IUPAC Names": "(4S)-2,5,5-trimethyl-1,3-thiazolidine-4-carboxylic acid", "SMILES": "CC1N[C@@H](C(O)=O)C(C)(C)S1", "Mass": 175.249, "Molfile": "\n\n  Marvin  02021018362D          \n\n 11 11  0  0  0  0            999 V2000\n   -0.8250    1.0848    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.4924    0.5999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   -1.2375   -0.1847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.4125   -0.1847    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0\n   -0.1576    0.5999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.4258    1.1832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.5569    0.1874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.1709   -0.7681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    0.9959   -0.7681    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -0.0427   -1.5650    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   -2.2893    0.8134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  1  2  1  0  0  0  0\n  1  5  1  0  0  0  0\n  2  3  1  0  0  0  0\n  3  4  1  0  0  0  0\n  4  5  1  0  0  0  0\n  5  6  1  0  0  0  0\n  5  7  1  0  0  0  0\n  4  8  1  6  0  0  0\n  8  9  1  0  0  0  0\n  8 10  2  0  0  0  0\n  2 11  1  0  0  0  0\nM  END", "PubMed Citation Links": ["7716788"], "Synonyms": ["(S)-2,5,5-Trimethyl-thiazolidine-4-carboxylic acid"], "Monoisotopic Mass": ["175.067"], "PubChem Database Links": ["CID: 2725071", "SID: 85340731"], "Beilstein Registry Numbers": ["4462"], "Charge": 0, "ChEBI ID": "CHEBI:141059", "Formulae": "C7H13NO2S", "InChI": "InChI=1S/C7H13NO2S/c1-4-8-5(6(9)10)7(2,3)11-4/h4-5,8H,1-3H3,(H,9,10)/t4?,5-/m0/s1", "ChEBI Name": "(S)-2,5,5-trimethylthiazolidine-4-carboxylic acid"}
{"Definition": "The trisodium salt of phosphonoformic acid. It is used as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.", "InChIKey": "DFHAXXVZCFXGOQ-UHFFFAOYSA-K", "Star": 3, "SMILES": "[Na+].[Na+].[Na+].[O-]C(=O)P([O-])([O-])=O", "Mass": 191.9508, "Molfile": "\n\n  Marvin  09151010322D          \n\n 10  6  0  0  0  0            999 V2000\n    3.5684   -3.8168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.5684   -2.9919    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    2.8538   -4.2293    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0\n    4.2828   -4.2293    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n    2.1394   -3.8168    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n    2.8538   -5.0543    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n    2.6439   -3.4292    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0\n    4.2641   -5.1885    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n    2.5644   -2.6340    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n    1.4611   -3.1707    0.0000 Na  0  3  0  0  0  0  0  0  0  0  0  0\n  1  2  2  0  0  0  0\n  1  3  1  0  0  0  0\n  1  4  1  0  0  0  0\n  3  5  1  0  0  0  0\n  3  6  2  0  0  0  0\n  3  7  1  0  0  0  0\nM  CHG  6   4  -1   5  -1   7  -1   8   1   9   1  10   1\nM  END", "DrugBank Database Links": ["DB00529"], "Secondary ChEBI ID": "CHEBI:5161", "Synonyms": ["FOSCARNET SODIUM", "foscarnet sodium", "trisodium carboxyphosphate", "trisodium carboxyphosphate (anhydrous)", "trisodium dioxidophosphinecarboxylate oxide", "trisodium phosphonoformate", "trisodium phosphonoformate (anhydrous)"], "Monoisotopic Mass": ["191.918"], "PubChem Database Links": ["CID: 44561", "CID: 4488958", "SID: 85341314"], "Charge": 0, "ChEBI ID": "CHEBI:141644", "Formulae": "CNa3O5P", "InChI": "InChI=1S/CH3O5P.3Na/c2-1(3)7(4,5)6;;;/h(H,2,3)(H2,4,5,6);;;/q;3*+1/p-3", "ChEBI Name": "trisodium phosphonoformate", "CAS Registry Numbers": ["63585-09-1"], "INN": ["foscarnet sodique", "foscarnet sodium", "foscarneto sodico", "foscarnetum natricum"], "KEGG DRUG Database Links": ["D00579"]}
{"Definition": "A 1,5-dihydroimidazo[2,1-<ital></ital>]quinazoline having an oxo substituent at the 2-position and chloro substituents at the 6- and 7-positions.", "InChIKey": "OTBXOEAOVRKTNQ-UHFFFAOYSA-N", "Star": 3, "IUPAC Names": "6,7-dichloro-1,5-dihydroimidazo[2,1-]quinazolin-2(3H)-one", "SMILES": "Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl", "Mass": 256.088, "Molfile": "\n\n  Marvin  01061010142D          \n\n 16 18  0  0  0  0            999 V2000\n    4.5232   -0.7732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    4.5232    0.0454    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    3.0756    0.0454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.7862   -1.1938    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    3.0756   -0.7732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    3.7862    0.4718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.3593    0.4547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.6600    0.0454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.3593   -1.1825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    1.6600   -0.7732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    2.3593    1.2734    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0\n    0.9437    0.4547    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0\n    5.3079    0.3067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    5.3079   -1.0281    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n    5.7928   -0.3607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    6.6178   -0.3607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n  3  5  1  0  0  0  0\n  4  1  2  0  0  0  0\n  5  4  1  0  0  0  0\n  6  2  1  0  0  0  0\n  7  3  2  0  0  0  0\n  8 10  2  0  0  0  0\n  9  5  2  0  0  0  0\n 10  9  1  0  0  0  0\n 11  7  1  0  0  0  0\n 12  8  1  0  0  0  0\n  6  3  1  0  0  0  0\n  8  7  1  0  0  0  0\n  1 14  1  0  0  0  0\n  2  1  1  0  0  0  0\n 13  2  1  0  0  0  0\n 14 15  1  0  0  0  0\n 13 15  1  0  0  0  0\n 15 16  2  0  0  0  0\nM  END", "DrugBank Database Links": ["DB00261"], "KEGG DRUG Database Links": ["D07455"], "INN": ["anagrelida", "anagrelide", "anagrelidum"], "Monoisotopic Mass": ["254.997"], "LINCS Database Links": ["LSM-3380"], "PubChem Database Links": ["CID: 2182", "SID: 85341952"], "Beilstein Registry Numbers": ["619582"], "Charge": 0, "ChEBI ID": "CHEBI:142290", "Formulae": "C10H7Cl2N3O", "InChI": "InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)", "ChEBI Name": "anagrelide", "CAS Registry Numbers": ["68475-42-3"], "Wikipedia Database Links": ["Anagrelide"]}
{"Definition": "A carboxylic acid that is 3-phenylpropanoic acid substituted at position 4 by a 2-hydroxy-3-(propan-2-ylamino)propoxy group.", "InChIKey": "ILSCWPMGTDPATI-UHFFFAOYSA-N", "Star": 3, "IUPAC Names": "3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid", "SMILES": "CC(C)NCC(O)COc1ccc(CCC(O)=O)cc1", "Mass": 281.3474, "Molfile": "\n\n  Marvin  08171014542D          \n\n 20 20  0  0  0  0            999 V2000\n   18.4778  -31.9471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   18.4764  -30.6163    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   11.5741  -26.6202    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1737  -26.6370    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   13.8737  -26.6287    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1737  -27.9670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   17.3265  -32.6129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   12.7304  -25.9630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1737  -30.6179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0300  -25.9715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   19.6306  -32.6121    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   16.1737  -31.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   17.3265  -28.6224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0300  -28.6225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   17.3265  -29.9524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   15.0300  -29.9525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   13.8607  -27.9516    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\n   10.4264  -25.9466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n   10.4349  -24.6158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n    9.2697  -26.6040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\n  2  1  2  0  0  0  0\n  7  1  1  0  0  0  0\n 11  1  1  0  0  0  0\n  8  3  1  0  0  0  0\n 18  3  1  0  0  0  0\n  6  4  1  0  0  0  0\n 10  4  1  0  0  0  0\n 10  5  1  0  0  0  0\n  8  5  1  0  0  0  0\n 17  5  1  0  0  0  0\n 14  6  2  0  0  0  0\n 13  6  1  0  0  0  0\n 12  7  1  0  0  0  0\n 12  9  1  0  0  0  0\n 15  9  1  0  0  0  0\n 16  9  2  0  0  0  0\n 15 13  2  0  0  0  0\n 16 14  1  0  0  0  0\n 19 18  1  0  0  0  0\n 20 18  1  0  0  0  0\nM  END", "Synonyms": ["3-{4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl}propionic acid"], "Monoisotopic Mass": ["281.163"], "PubChem Database Links": ["CID: 133620", "SID: 85342954"], "Charge": 0, "ChEBI ID": "CHEBI:143310", "Formulae": "C15H23NO4", "InChI": "InChI=1S/C15H23NO4/c1-11(2)16-9-13(17)10-20-14-6-3-12(4-7-14)5-8-15(18)19/h3-4,6-7,11,13,16-17H,5,8-10H2,1-2H3,(H,18,19)", "ChEBI Name": "3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoic acid", "CAS Registry Numbers": ["81148-15-4"]}
